J&J Vaccine To Remain In Limbo While Officials Seek Evidence

J&J Vaccine To Remain In Limbo While Officials Seek Evidence

Johnson & Johnson’s COVID-19 vaccine will remain in limbo a while longer after U.S. health advisers told the government Wednesday that they need more evidence to decide if a handful of unusual blood clots were linked to the shot - and if so, how big the potential risk really is. But the government recommended a pause in…